Loading...
Loading...
AcelRx Pharmaceuticals,
Inc.
ACRX, announced today that the underwriters of its public
offering have exercised, in full, their option to purchase an additional
1,875,000 shares of common stock at a public offering price of $3.31 per
share. This option to purchase additional shares was granted to the
underwriters in connection with AcelRx's previously announced underwritten
public offering of 12,500,000 shares of its common stock, which was closed on
December 12, 2012. The sale of option shares was closed on December 14, 2012.
With the exercise of this option, the total gross proceeds of the public
offering increased to approximately $47.6 million with estimated net proceeds
to AcelRx of $44.2 million after deducting underwriting discounts and
estimated expenses.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in